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We often observe the discrepancy between the 
results obtained from in vitro and in vivo studies. Many 
substances were proved to act perfectly in vitro stu­
dies, but their in vivo action was usually unsuccessful. 
One can argue that these divergences are connected 
with in vitro models, which are based on the immor­
talized and commercially available cell lines. Striking 
differences between results establishing on cell culture 
systems vs animal models are even observed if the 
primary cell cultures were used. 
Normal prostate epithelial stem cells were identi­
fied and found to have a basal cell phenotype together 
with the expression of CD133 antigen [1]. The estab­
lishment of the isolation method of CD133+ single­
stem cell suspension from adult prostatic tissue was 
reported [2]. It was proven on rat model that progenitor 
cells were responsible for establishing the primary 
prostate epithelial cultures [3]. 
In this paper we analyzed the short­term primary 
culture of CD133 immunolabeled and sorted cells from 
epithelium of patients suffering from benign prostate 
hyperplasia (BPH). We will try to find the differences 
of cell viability and morphology between CD133 sorted 
cells during the formation of monolayers.
METHODS
Prostate epithelium cell culture CD133+/
CD133–. Prostate specimens were obtained from 
5 patients suffering from BPH treated by an open 
prostatectomy. Specimens of ca. 2 cm3 were resected 
from central zone. Specimens were chopped into 
small pieces of 0.5 x 0.5 x 0.5mm in order to facilitate 
enzyme access to epithelial cells. Tissue was digested 
6 h with 0.5% colagenase (Sigma, Germany) in a stir­
rer. Cell suspensions obtained after digestion were 
passed through 30 µm mesh (Sigma) to remove cell 
clumps. Digested cells were counted using trypan blue 
exclusion assay.  Homogenous cell suspensions were 
divided into two equal fractions. Cells from the first 
part were seeded on 25 cm2 T­flasks. These cultures 
were considered as CD133+/CD133– and cultivated in 
DMEM with 10% FBS and supplements in atmosphere 
of 5% CO2 with suitable humidity. Due to extensive 
culture growth medium was changed every two days. 
The first medium exchange was partially, i. e. only 
half of medium was removed and then in the next 
procedures always the whole volume of medium was 
changed. The epithelial nature was confirmed using 
anti­cytokeratine antibody (Pancytokeratine, clone 
MMF118, Dako, Denmark). Procedures were approved 
by Local Bioethical Committee.
CD133+ cells magnetic isolation, CD133+ and 
CD133– culture. Phosphate buffered saline pH 7.2 
supplemented with 0.5% bovine serum albumin (Gib­
co) and 2 mM EDTA (Sigma) was prepared. Buffer was 
degassed in the ultrasound bath and kept in the refrig­
erator. Cells from the second fraction were suspended 
in 300 µl degassed buffer. 100 µl FcR Blocking Reagent 
was added to inhibit unspecific binding of antibodies 
to non­target cells. Cold solutions were used to avoid 
capping of antibodies on the cell surface during la­
beling and avoid nonspecific cell labeling. Cells were 
labeled by adding 100 µl CD133 MACS MicroBeads 
(Miltenyi Biotec, Bergish Gladbach, Germany). Sus­
pensions were mixed and incubated for 30 min at 4 °C. 
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Cells were washed by adding 10 x the volume of buf­
fer and centrifuged at 300 g for 10 min. Supernatant 
was removed and pellet was re­suspended in 500 µl 
buffer. MS Columns (Miltenyi Biotec) were used for 
magnetic separation in SuperMACS II device (Miltenyi 
Biotec). After pre­wash of the column with 500 µl of 
buffer, cell suspension was applied onto the column to 
allow the non­labeled cells to pass through. Then the 
column was washed with 2000 µl of buffer. Obtained 
cell suspension was collected in T­flask and cultivated 
in conditions described above. This culture was con­
sidered as CD133–. Then the column was removed 
from magnetic field and placed on collection tube. 
Magnetically labeled cells were flushed out by using 
1000 µl of buffer. CD133+ cell suspension obtained in 
this way was cultivated. In these cultures medium was 
changed for the first time after 4 days and then every 
3 days till the end of experiment. Medium in CD133– 
cultures was changed only 3 times during observation 
period. The first medium changing was partially, in or­
der to protect unattached living cells. After two weeks 
of culture cells growing in monolayers were counted 
again using trypan blue exclusion assay. 
Flow cytometry study. Living, apoptotic and 
necrotic cells were counted after 2 weeks of culture. 
In order to detect living and apoptotic cells by flow 
cytometry Annexin V conjugated with fluoresceine 
isothiocyanate (Annexin V–FITC) and propidium iodide 
(PI) staining kit (Immunotech, Beckman­Coulter, US) 
was used. Living cells were negative for Annexin V­
FITC and PI. Early apoptotic cells were detected after 
binding with Annexin V­FITC. Secondary necrotic cells 
stained positively both for Annexin V­FITC and PI. It is 
presumed that secondary necrotic cells died in apop­
totic process. Necrotic cells stained with PI. For flow 
cytometry study all cells from both monolayers and 
suspensions were counted using trypan blue exclusion 
assay. Then 105 centrifuged cells were suspended in 
0.5 ml of binding buffer containing 0.05 ml Annexin 
V­FITC and 0.05 ml PI. The analysis was performed 
using the FC 500 flow cytometer (Beckman­Coulter, 
Miami Fl, US) with CPX Software. All experiments were 
performed at least in triplicate. 
RESULTS
Material for 132 separate cultures was isolated. 
70 cultures were CD133+/CD133–, 31 were CD133+ 
and 31 were CD133–. Each CD133+/CD133– culture 
had approximately 4.0 ± 0.1x105 isolated cells. Each 
CD133+ labeled fraction had the mean number of 
3.0 ± 0.1 x 104 cells. Each fraction of non­labeled cells 
had 3.5 ± 0.1 x 105 and was considered as CD133– 
culture. High proliferation rate within CD133+/CD133– 
cultures was observed (Fig. 1, a–e). There were 
approximately 2.0 ± 0.5 x 106 cells in each CD133+/
CD133– culture after 2 weeks of follow up (Fig. 2). 
CD133+ cultures showed lower proliferation rate dur­
ing the same observation period (Fig.1, f–k). The cell 
number of primary CD133+ fraction was triplicated 
up to 9.0 ± 0.4 x 104 cells in an each culture (Fig. 2). 
CD133+/CD133– and CD133+ monolayers displayed 
epithelial­like morphology (Fig. 1, e and k). CD133+/
CD133– colonies grew from groups of highly prolifera­
ted cells, which formed “nests”, immediately after iso­
lation (Fig. 1, a–c). The morphology and proliferation 
of CD133+/CD133– cultures resembled keratynocyes 
growth obtained after digestion of epidermal sheets 
[4, 5]. CD133+ colony has grown usually from single 
round­shape cell, but in the end of experiment the 
epithelial like monolayer was good visible (Fig. 1, f–h). 
It was possible to perform the first passage of CD133+/
CD133– and CD133+ cultures after 2 weeks of culture. 
There was sufficient cell number in flasks covered with 
cells growing in monolayers. No culture of anchor­
age cells from CD133– populations were obtained 
during the 2 weeks of observation (Fig. 1, m–r). The 
primary CD133– cultures collapsed within this period. 
The suspension containing only a few CD133– cells 
was observed (Fig. 1, r). 
CD133+ populations showed the highest viability, 
which reached 90.1 ± 6.3% and the lowest percent 
of the apoptotic cells (9.0 ± 6.1%). Moderate viability 
was found when CD133+/CD133– populations were 
examined. Among CD133– cultures percentage of 
living and apoptotic cells was 24.3 ± 6.2% and 28.5 ± 
23.8%, respectively (Fig. 3).
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Fig. 1. CD133+/CD133– cells in 0, 1, 2 and 7 days after enzymatic 
digestion of the human prostate (a–d). (e) The confluent CD133+/
CD133– epithelial­like culture can be observed in 2 weeks. The 
epithelial­like monolayers of CD133+/CD133– cells are growing 
from clusters of  characteristic nests (a). (f–j) Present CD133+ 
cells within the 0, 1, 2 and 7 days after isolation. (k) CD133+ cells 
form monolayers similar to CD133+/CD133– epithelial prostate 
culture obtained from simple tissue digestion after 2 weeks. 
(m–p) Present CD133+ cells within the 0, 1, 2 and 7 days after 
isolation. (r) CD133­ cultures failed to grow in two weeks upon 
cultivation (inverted microscope, magnification 100 x)
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Fig. 2. The mean cell numbers in monolayers (only attached 
cells were counted) within primary cultures of the CD133+/
CD133–, CD133+ and CD133–. Cells were counted using trypan 
blue exclusion test just after isolation, and then in two weeks 
upon cultivation. CD133– cells did not form monolayer in 2 weeks 
upon cultivation
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Fig. 3. The percentage of living, apoptotic and necrotic cells 
within the each primary culture of CD133+/CD133–, CD133+ and 
CD133– populations in 2 weeks upon cultivation
DISCUSSION
Prostate epithelial stem cells are self­renewing 
cells capable of differentiation into prostate epithe­
lium. Rodent models and immortalized or genetically 
modified cell lines are frequently used, but with lim­
ited utility for studying human prostate development. 
Adult stem cells (ASC) and transit­amplifying cells 
(TAC) have been observed in many tissues including 
prostate [6]. Epithelial cells probably share common 
stem cell markers [7]. Analysis of stage­specific 
differentiation markers has revealed that prostate 
stem cells were characterized by following markers: 
CD133+/ABCG2+/α(2)β(1)(Hi). These cells were able 
to self­renew and generate two distinct cell lineages. 
CD133–/ABCG2–/α(2)β(1)(Hi)/p63+/PSCA–/AR–/
PSA– were identified as transit­amplifying cells, while 
CD133­/ABCG2/α(2)β(1)(Lo)/p63–/PSCA+/AR–/PSA– 
were intermediate quiescent cells. Luminal­secretory 
cells were described as CD133–/ABCG2­/α(2)β(1)(Lo)/
p63–/PSCA–/AR+/PSA+ [8]. It was shown that isolation 
of stem cells from normal and malignat prostate may 
now be possible [1, 3, 7, 9, 10]. 
There are two populations of cells capable of re­
generating prostatic tissue. The first population (with 
considerable growth potential) resides in the proximal 
region of ducts and in the urethra, and the survival of 
these cells does not require the presence of andro­
gens. The second population (with more limited growth 
potential) is found in the remaining ductal regions and 
requires androgens for survival [11]. We proved that 
CD133– cells had no potential for in vitro proliferation, 
even in the serum conditioned medium. Serum was 
used in this experiment due to obtain high cell viability 
and to facilitate anchorage growth in culture. We think 
that serum influence on differentiation during this 
short experiment was minimal. It can be speculated 
that these cells (CD133–) probably have no ability to 
regenerate the prostate ducts in vivo, but it should be 
checked on animal model. 
Richardson et al. [2] found that 1% of human 
prostate basal cells express the cell surface marker 
CD133. These cells (CD133+) expressed α(2)β(1)
(Hi) previously shown to be a marker of stem cells in 
prostate epithelia. We observed in our study that after 
isolation even 7% of cells were in CD133+ fraction. This 
can be partialy explained by the fact, that cultures were 
established from BPH patients. There is a suspicion 
that BPH development originates from disturbances 
of stem cell proliferation. In proliferative diseases 
homeostasis of cell number is disrupted. Increased 
ability of stem cells to mitosis can lead deregulation 
of epithelial lining [7, 9, 12]. The second reason is that 
samples for culture were taken from central part of the 
prostate, including proximal parts of prostatic ducts. 
The proximal region has been suggested as the stem 
cell niche [12]. We obtained samples from the central 
zone located close to the urethra, where the possibility 
to isolate more CD133+ cells seemed to be higher. 
It was interesting that co­cultures of CD133+ and 
CD133– populations have the higher proliferation rate, 
5­fold increase of cell number during the two weeks 
(Fig. 2). On the second hand these co­cultures where 
characterized by moderate cell viability (Fig. 3). We 
think that the source of high proliferation rate within 
these cultures comes from cell­to­cell interactions 
and cannot be simply characterized by cell viability 
or apoptotic assays. The behavior of CD133+ cells in 
culture resembled progenitors properties. The viability 
of these cells after detachment reached 100% in some 
cases, but proliferation rate was lower when comparing 
to CD133+/CD133– co­cultures. CD133– cultures are 
probably composed of differentiated cells without clo­
nogenic potential. These cells were not able to anchor 
and form monolayer. Some of them were still alive, but 
the most of them enter apoptotic pathway. The apop­
totic induction amnong these cells were probably due 
to lack of anchorage growth [13, 14]. The behavior of 
separated cells is converged with the description of 
naturally occurring cell senescence process within the 
prostate epithelium [15]. We think that in experiment 
performed on primary cell culture at least three parts 
of growing tissue i. e.; progenitors, differentiating and 
committed to die cells have to be separately analyzed. 
There is an increasing evidence that stem cells are 
responsible for both cancer development and cancer 
treatment failure [5, 12]. In this light, it is very important 
to plan the in vitro experiment on benign or cancer 
cells with the use of these separated populations. 
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These suggestions are related also to established and 
commercially available cell lines [16]. Experiments 
performed on cell lines never considered progenitors 
as a part of tested cell population. May by this is the 
reason of discrepancy between the results obtained 
from in vitro and in vivo experiments [17]. We postulate 
that cell sorting would come closer results from in vitro 
experiments to in vivo conditions. If one analyses the 
cell viability its clear that CD133+/CD133– viability is “a 
mean” calculated from CD133+ and CD133– viability 
(see Fig. 3). The similar can be observed when apop­
totic index was analyzed. The number of apoptotic cells 
within CD133+/CD133– population can be estimated as 
“a mean” calculated from CD133+ and CD133– alone, 
but this simplistic model cannot answer the questions 
arising from experiments where new substances or 
drugs are tested in vitro. It is, of course difficult or 
even impossible to predict results of such performed 
experiments, but it can be speculated that CD133+ and 
CD133– cells would react in different ways. Immuno­
magnetic labeling is a simple method for cell sorting, 
which can be applied in every in vitro experiment to 
provide more objective results.
CONCLUSIONS
Epithelial progenitors are necessary to establish 
human primary prostate epithelial cultures in vitro. 
Interactions between stem and differentiated cells 
are crucial for growth and proliferation within pros­
tate epithelial monolayers in vitro. Separated human 
primary epithelial cells fractions displayed differences 
in morphology, viability and apoptosis occurrence. 
Immunomagnetic labeling is a simple method for cell 
sorting, which can be applied in every in vitro experi­
ment to improve results.
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РОЛЬ КЛЕТОК-ПРЕДШЕСТВЕННИКОВ В ФОРМИРОВАНИИ 
ПЕРВИЧНЫХ ЭПИТЕЛИАЛЬНЫХ КЛЕТОЧНЫХ ЛИНИЙ РАКА 
ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ
Цель: оценить жизнеспособность и морфологию клеток первичных клеточных культур, полученных из меченных по CD133 
и полученных с помощью клеточной сортировки клеток эпителия пациентов с доброкачественной гиперплазией предста-
тельной железы (BPH). Методы: клетки, полученные от 5 пациентов, были разделены на 2 фракции. Первую фракцию 
(CD133+/CD133–) выращивали в DMEM с 10% FBS. �торую фракцию сме�али с CD133 магнитными гранулами и с по-
мощью магнита разделили клетки на CD133+- и CD133–-фракции. Далее клетки культивировали в течении 2 нед. Клетки 
окра�ивали аннексином V FITC/пропидий йодидом. Результаты: получено 70 CD133+/CD133--культур клеток, 31 CD133+ 
и 31 CD133–. Через 2 нед культивирования отмечали 5-кратное и 3-кратное увеличение количества CD133+/CD133– и 
CD133+ клеток соответственно. CD133+/CD133-- и CD133+-клетки росли в монослое и имели морфологию эпителиальных 
клеток, экспрессировали цитокератин. CD133–-клетки не выжили. �ыживаемость клеток в популяциях CD133+ и CD133– 
была 90,1 ± 6,3% и 24,3 ± 6,2% соответственно. Показатель апоптического индекса для культур CD133+ и CD133– был 
9,0 ± 6,1% и 28,5 ± 23,8% соответственно. Выводы: показаны различия в морфологии, выживаемости клеток и частоте 
апоптоза для эпителиальных клеток, разделенных в зависимости от экспрессии CD133. Сортировка клеток с помощью 
иммуномагнитного разделения рекомендована для каждого in vitro эксперимента с использованием первичных клеточных 
культур для получения более объективных результатов. 
Ключевые слова: первичные эпителиальные клеточные линии, предстательная железа, доброкачественная гиперплазия 
предстательной железы, выживаемость, апоптоз, проточная цитометрия.
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